Case Studies on Recent Global Pharma and Biopharma Patent Laws to be Discussed at CPhI's Pharma IPR Conference in India
MUMBAI, January 9, 2014 /PRNewswire/ --
As per a recent industry report, numerous drugs are going off patent from 2011-2015, thereby creating a huge opportunity for Indian generic players to capture the unexplored and semi regulated markets. But to capitalise on this huge opportunity, Indian generic players will have to play a strategic role in terms of dealing with the domestic competitors as well as MNCs having a generic hand.
However, with the recent reforms within the intellectual property laws in various countries, Indian pharma and biopharma companies are looking to gain more information about these latest updates through reference of different case studies globally.
CPhI's 3rd Annual Pharma IPR 2014, taking place from 26-28 February in Mumbai, India, is a targeted conference focusing on similar patent related matters for pharma and biopharma industry across the globe. It is intended to provide an ideal learning and networking platform where techno-legal experts from patent law firms across the globe share an update on patent regimes, changes in patent laws, and enforceability of patent laws in different regions with the pharma and biopharma companies.
For the last two years, this patent-focused summit has been successful in answering patent related queries of IPR, legal and international business development heads from Indian pharma and biopharma companies.
The conference agenda will cover most debated subjects like: inter-partes review; one year after the implementation of the America Invents Act; reverse payments settlements cases; current implementation of the Unitary Patent System in EU; and formulating strategies to introduce generic products in international markets.
The programme will cover patent laws of over 13 regions including the US, EU, Japan, Mexico, Canada, India, South East Asia, and Gulf Corporation Council (GCC) countries.
Region wise agenda can be viewed by clicking here.
To maximise interactive learning and networking between industry and global legal fraternity, customised formats have been introduced. To view some of Pharma 2013 highlights, click here.
Find out more about 3rd annual Pharma IPR Conference: www.pharmaipr-india.com
CPhI is a UBM brand, and is the largest and most important meeting place for the Indian pharma industry. Each year CPhI attracts around 850 exhibitors and 30,000 visitors to the show, providing us with an unrivalled reach to all the key decision makers in the Indian pharma industry.
About UBM India
UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughout India and in the publications of trade journals and magazines. For further details, please visit the UBM India website: www.ubmindia.in
Primary Media Contact: Ms Suvidha Shetty, email@example.com, 91-22-6172 7001
Secondary Media Contact: Shrutika Shetty, firstname.lastname@example.org, 91-22-61727067
SOURCE UBM India Pvt. Ltd.
More by this Source
CPhI மற்றும் P-MEC இந்தியா 'Pharma Week 2016' மூலம் பெரிதாகிறது
Feb 12, 2016, 12:55 IST
CPhI અને P-MEC Indiaની "ફાર્મા વીક 2016" સાથે થયેલી વૃદ્ધિ
Feb 12, 2016, 12:53 IST
CPhI और P-MEC इण्डिया 'Pharma Week 2016' के साथ और अधिक बड़े हो रहे हैं
Feb 12, 2016, 12:45 IST
Get content for your website
Enhance your website's or blog's content with PR Newswire's customised real-time news feeds.
Become a PR Newswire client
Request more information about PR Newswire products & services or call us at +91 22 6169 6000